In a statement, the FDA stood by its rejection [of over-the-counter sale of EC] and said the audit "mischaracterizes facts."
"We question the integrity of the investigative process that results in such partial conclusions," the agency said.
hold on.
the FDA is accusing someone of being unfairly partial? and that someone is...the GAO?
my brain is leaking out my ears a little.
No comments:
Post a Comment